Vitamin B12, Folic Acid and Vitamin D Status in Women of Reproductive Age

NCT07100795 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 360

Last updated 2026-05-06

No results posted yet for this study

Summary

This cross-sectional observational study aims to assess serum concentrations of vitamin B12, folic acid, and vitamin D in women of reproductive age in Herzegovina. The study is led by Professor Vajdana Tomić, MD, PhD, who serves as the Principal Investigator, at the Faculty of Health Studies, University of Mostar, Bosnia and Herzegovina. The goal is to determine whether current international supplementation guidelines reflect the actual micronutrient status of this population. A total of 360 women aged 18-49 will be enrolled between December 2024 and December 2025 after providing informed consent. The findings will inform population-specific recommendations for micronutrient supplementation during the preconception period and pregnancy.

The study will be conducted at the Faculty of Health Studies, University of Mostar, Bosnia and Herzegovina.

Conditions

  • Vitamin D, Vitamin B 12 and Folic Acid Concentrations
  • Micronutrient Status in Women of Reproductive Age
  • Vitamin Status Assessment

Interventions

OTHER

No Interventions

This is an observational study. No intervention will be administered. Participants will provide blood samples for micronutrient analysis.

Sponsors & Collaborators

  • Faculty of Health Studies - University of Mostar

    collaborator UNKNOWN
  • Primary Health Care Center Mostar

    collaborator UNKNOWN
  • University Clinical Hospital Mostar

    collaborator OTHER
  • University of Mostar

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-12-23
Primary Completion
2026-12-01
Completion
2026-12-01

Countries

  • Bosnia and Herzegovina

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07100795 on ClinicalTrials.gov